BIOGEN INC. (BIIB) capitalization

Current snapshot

Market Cap
$27.07B
147.6M shares × $183.33 · as of last filing 2026-03-31
Net Worth
$18.65B
Stockholders' equity · 2026-03-31
Enterprise Value
$30.25B
Market cap + debt − cash
Net Debt
$3.18B
Debt $6.56B − Cash $3.38B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $25.89B
FY'24 2024-12-31 $22.31B
FY'23 2023-12-31 $37.68B
FY'22 2022-12-31 $40.43B
FY'21 2021-12-31 $35.89B
FY'20 2020-12-31 $39.50B
FY'19 2019-12-31 $55.61B
FY'18 2018-12-31 $61.78B
FY'17 2017-12-31 $67.86B
FY'18 2017-02-01
FY'16 2016-12-31 $62.05B
FY'15 2015-12-31 $70.83B
FY'14 2014-12-31 $80.52B
FY'13 2013-12-31 $66.62B
FY'12 2012-12-31 $35.09B
FY'11 2011-12-31 $26.97B
FY'10 2010-12-31 $17.09B
FY'09 2009-12-31 $15.49B
FY'09 2008-12-31 $14.05B
FY'09 2007-12-31 $18.22B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $27.21B
Q4'25 2025-12-31 $25.84B
Q3'25 2025-09-30 $20.61B
Q2'25 2025-06-30 $18.42B
Q1'25 2025-03-31 $20.06B
Q4'24 2024-12-31 $22.30B
Q3'24 2024-09-30 $28.32B
Q2'24 2024-06-30 $33.82B
Q1'24 2024-03-31 $31.46B
Q4'23 2023-12-31 $37.50B
Q3'23 2023-09-30 $37.22B
Q2'23 2023-06-30 $41.45B
Q1'23 2023-03-31 $40.37B
Q4'22 2022-12-31 $39.88B
Q3'22 2022-09-30 $38.66B
Q1'22 2022-06-30 $29.82B
Q1'22 2022-03-31 $31.08B
Q4'21 2021-12-31 $35.27B
Q3'21 2021-09-30 $42.05B
Q2'21 2021-06-30 $51.98B
Q1'21 2021-03-31 $42.61B
Q4'20 2020-12-31 $37.32B
Q3'20 2020-09-30 $44.59B
Q2'20 2020-06-30 $43.05B
Q1'20 2020-03-31 $54.77B
Q4'19 2019-12-31 $51.69B
Q3'19 2019-09-30 $42.89B
Q2'19 2019-06-30 $44.53B
Q1'19 2019-03-31 $46.57B
Q4'18 2018-12-31 $59.34B
Q3'18 2018-09-30 $71.33B
Q2'18 2018-06-30 $60.17B
Q1'18 2018-03-31 $57.97B
Q4'17 2017-12-31 $67.38B
Q3'17 2017-09-30 $66.32B
Q2'17 2017-06-30 $57.58B
Q1'17 2017-03-31 $59.03B
Q4'18 2017-02-01
Q4'16 2016-12-31 $61.22B
Q3'16 2016-09-30 $68.68B
Q2'16 2016-06-30 $53.06B
Q1'16 2016-03-31 $57.09B
Q4'15 2015-12-31 $66.97B
Q3'15 2015-09-30 $67.88B
Q2'15 2015-06-30 $95.21B
Q1'15 2015-03-31 $99.48B
Q4'14 2014-12-31 $79.63B
Q3'14 2014-09-30 $78.40B
Q2'14 2014-06-30 $74.85B
Q1'14 2014-03-31 $72.74B
Q4'13 2013-12-31 $66.07B
Q3'13 2013-09-30 $57.38B
Q2'13 2013-06-30 $51.38B
Q1'13 2013-03-31 $45.90B
Q4'12 2012-12-31 $34.63B
Q3'12 2012-09-30 $35.53B
Q2'12 2012-06-30 $34.74B
Q1'12 2012-03-31 $30.47B
Q4'11 2011-12-31 $26.64B
Q3'11 2011-09-30 $22.86B
Q2'11 2011-06-30 $26.19B
Q1'11 2011-03-31 $17.97B
Q4'10 2010-12-31 $16.13B
Q3'10 2010-09-30 $13.60B
Q2'10 2010-06-30 $12.42B
Q1'10 2010-03-31 $15.65B
Q4'09 2009-12-31 $14.70B
Q3'09 2009-09-30 $14.70B
Q2'09 2009-06-30 $13.11B
Q1'10 2009-03-31 $15.19B
Q4'09 2008-12-31 $13.72B
Q3'09 2008-09-30 $14.78B
Q2'09 2008-06-30 $16.40B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (BIIB CIK 0000875045), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

AVIR

Atea Pharmaceuticals, Inc.

HOV

HOVNANIAN ENTERPRISES, INC.

RHI

ROBERT HALF INC.